Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380

Barbara J. Caldarone, Daguang Wang, Neil E. Paterson, Michael Manzano, Allison Fedolak, Katie Cavino, Mei Kwan, Taleen Hanania, Sheela K. Chellappan, Alan P. Kozikowski, Berend Olivier, Marina R. Picciotto, Afshin Ghavami

Research output: Contribution to journalArticle

Abstract

Rationale Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans. Objectives The study determined whether the antidepressantlike effect of the nAChR β2*partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2*nAChRs. The study also determined if sazetidine's behavioral responses in the forced swim test corresponded to β2*nAChRs receptor occupancy and drug bioavailability. Results Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2*agonist 5-IA8350 (BALB/cJ mice) and the less selective β2*partial agonist varenicline in C57BL/6J but not BALB/cJ mice. The role of β2*nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2*receptor occupancy. β2*receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test. Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing. Conclusions Results demonstrate that activation of a small population of β2*nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2*nAChRs would be promising targets for the development of a new class of antidepressant.

Original languageEnglish (US)
Pages (from-to)199-210
Number of pages12
JournalPsychopharmacology
Volume217
Issue number2
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

A 85380
Nicotinic Receptors
Antidepressive Agents
Mecamylamine
Drug Receptors
Cholinergic Agonists
Cholinergic Antagonists
Biological Availability
Rodentia
Varenicline
Ligands
Population

Keywords

  • 5-I-A85380
  • AMOP-H-OH
  • Antidepressant
  • Forced swim
  • Nicotinic receptor
  • Receptor occupancy
  • Sazetidine-A
  • Varenicline

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. / Caldarone, Barbara J.; Wang, Daguang; Paterson, Neil E.; Manzano, Michael; Fedolak, Allison; Cavino, Katie; Kwan, Mei; Hanania, Taleen; Chellappan, Sheela K.; Kozikowski, Alan P.; Olivier, Berend; Picciotto, Marina R.; Ghavami, Afshin.

In: Psychopharmacology, Vol. 217, No. 2, 09.2011, p. 199-210.

Research output: Contribution to journalArticle

Caldarone, BJ, Wang, D, Paterson, NE, Manzano, M, Fedolak, A, Cavino, K, Kwan, M, Hanania, T, Chellappan, SK, Kozikowski, AP, Olivier, B, Picciotto, MR & Ghavami, A 2011, 'Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380', Psychopharmacology, vol. 217, no. 2, pp. 199-210. https://doi.org/10.1007/s00213-011-2271-y
Caldarone, Barbara J. ; Wang, Daguang ; Paterson, Neil E. ; Manzano, Michael ; Fedolak, Allison ; Cavino, Katie ; Kwan, Mei ; Hanania, Taleen ; Chellappan, Sheela K. ; Kozikowski, Alan P. ; Olivier, Berend ; Picciotto, Marina R. ; Ghavami, Afshin. / Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. In: Psychopharmacology. 2011 ; Vol. 217, No. 2. pp. 199-210.
@article{dc0a2887040f492c844a5b94ddcc4912,
title = "Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380",
abstract = "Rationale Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans. Objectives The study determined whether the antidepressantlike effect of the nAChR β2*partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2*nAChRs. The study also determined if sazetidine's behavioral responses in the forced swim test corresponded to β2*nAChRs receptor occupancy and drug bioavailability. Results Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2*agonist 5-IA8350 (BALB/cJ mice) and the less selective β2*partial agonist varenicline in C57BL/6J but not BALB/cJ mice. The role of β2*nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2*receptor occupancy. β2*receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test. Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing. Conclusions Results demonstrate that activation of a small population of β2*nAChRs (10-40{\%}) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2*nAChRs would be promising targets for the development of a new class of antidepressant.",
keywords = "5-I-A85380, AMOP-H-OH, Antidepressant, Forced swim, Nicotinic receptor, Receptor occupancy, Sazetidine-A, Varenicline",
author = "Caldarone, {Barbara J.} and Daguang Wang and Paterson, {Neil E.} and Michael Manzano and Allison Fedolak and Katie Cavino and Mei Kwan and Taleen Hanania and Chellappan, {Sheela K.} and Kozikowski, {Alan P.} and Berend Olivier and Picciotto, {Marina R.} and Afshin Ghavami",
year = "2011",
month = "9",
doi = "10.1007/s00213-011-2271-y",
language = "English (US)",
volume = "217",
pages = "199--210",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380

AU - Caldarone, Barbara J.

AU - Wang, Daguang

AU - Paterson, Neil E.

AU - Manzano, Michael

AU - Fedolak, Allison

AU - Cavino, Katie

AU - Kwan, Mei

AU - Hanania, Taleen

AU - Chellappan, Sheela K.

AU - Kozikowski, Alan P.

AU - Olivier, Berend

AU - Picciotto, Marina R.

AU - Ghavami, Afshin

PY - 2011/9

Y1 - 2011/9

N2 - Rationale Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans. Objectives The study determined whether the antidepressantlike effect of the nAChR β2*partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2*nAChRs. The study also determined if sazetidine's behavioral responses in the forced swim test corresponded to β2*nAChRs receptor occupancy and drug bioavailability. Results Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2*agonist 5-IA8350 (BALB/cJ mice) and the less selective β2*partial agonist varenicline in C57BL/6J but not BALB/cJ mice. The role of β2*nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2*receptor occupancy. β2*receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test. Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing. Conclusions Results demonstrate that activation of a small population of β2*nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2*nAChRs would be promising targets for the development of a new class of antidepressant.

AB - Rationale Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans. Objectives The study determined whether the antidepressantlike effect of the nAChR β2*partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2*nAChRs. The study also determined if sazetidine's behavioral responses in the forced swim test corresponded to β2*nAChRs receptor occupancy and drug bioavailability. Results Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2*agonist 5-IA8350 (BALB/cJ mice) and the less selective β2*partial agonist varenicline in C57BL/6J but not BALB/cJ mice. The role of β2*nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2*receptor occupancy. β2*receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test. Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing. Conclusions Results demonstrate that activation of a small population of β2*nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2*nAChRs would be promising targets for the development of a new class of antidepressant.

KW - 5-I-A85380

KW - AMOP-H-OH

KW - Antidepressant

KW - Forced swim

KW - Nicotinic receptor

KW - Receptor occupancy

KW - Sazetidine-A

KW - Varenicline

UR - http://www.scopus.com/inward/record.url?scp=80054941854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054941854&partnerID=8YFLogxK

U2 - 10.1007/s00213-011-2271-y

DO - 10.1007/s00213-011-2271-y

M3 - Article

C2 - 21487659

AN - SCOPUS:80054941854

VL - 217

SP - 199

EP - 210

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -